Kundu R

References (2)

Title : DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes - Nag_2023_Future.Virol__
Author(s) : Nag S , Mandal S , Mukherjee O , Mukherjee S , Kundu R
Ref : Future Virol , : , 2023
Abstract : Nag_2023_Future.Virol__
ESTHER : Nag_2023_Future.Virol__
PubMedSearch : Nag_2023_Future.Virol__
PubMedID: 37064327

Title : Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections - Mani_2023_Int.J.Biol.Macromol_245_125444
Author(s) : Mani S , Kaur A , Jakhar K , Kumari G , Sonar S , Kumar A , Das S , Kumar S , Kumar V , Kundu R , Pandey AK , Singh UP , Majumdar T
Ref : Int J Biol Macromol , 245 :125444 , 2023
Abstract : Mani_2023_Int.J.Biol.Macromol_245_125444
ESTHER : Mani_2023_Int.J.Biol.Macromol_245_125444
PubMedSearch : Mani_2023_Int.J.Biol.Macromol_245_125444
PubMedID: 37385308
Gene_locus related to this paper: human-DPP4